Enveric Biosciences Inc. (NASDAQ:ENVB) price is hovering higher on Monday, September 13, jumping 13.48% above its previous close.
A look at today’s price movement shows that the recent level at last check reads $2.82, with intraday deals fluctuating between $2.77 and $3.419. The company’s P/E ratio in the trailing 12-month period read 0.99. Taking into account the 52-week price action we note that the stock hit a 52-week high of $15.04 and 52-week low of $1.54. The stock added 51.61% on its value in the past month.
Enveric Biosciences Inc., which has a market valuation of $61.31 million, is expected to release its quarterly earnings report Nov 15, 2021 – Nov 19, 2021. Analysts tracking ENVB have forecast the quarterly EPS to shrink by -0.14 per share this quarter, while the same analysts predict the annual EPS to hit -$0.63 for the year 2021 and up to -$0.54 for 2022.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give ENVB a short term outlook of 50% Buy on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Sell, while an average of long term indicators are currently assigning the stock as Hold.
Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Specifically, 2 analysts have assigned ENVB a recommendation rating as follows: 0 rate it as a Hold; 2 advise Buy while 0 analyst(s) assign an Overweight rating. 0 analyst(s) have tagged the Enveric Biosciences Inc. (ENVB) stock as Underweight, with 0 recommending Sell. In general, analysts have rated the stock Buy, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares.
The overview shows that ENVB’s price is at present 43.59% off the SMA20 and 52.73% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 65.74, with weekly volatility standing at 19.18%. The indicator jumps to 13.36% when calculated based on the past 30 days. Enveric Biosciences Inc. (NASDAQ:ENVB)’s beta value is holding at 1.63, while the average true range (ATR) indicator is currently reading 0.31. Considering analysts have assigned the stock a price target range of $6.00-$7.00 as the low and high respectively, we find the trailing 12-month average consensus price target to be $6.50. Based on this estimate, we see that today’s price at last check is roughly -87.5% off the estimated low and -118.75% off the forecast high. Investors will no doubt be excited to see the share price fall to $6.50, which is the median consensus price, and at that level ENVB would be -103.12% from recent price.
An analysis of the Enveric Biosciences Inc. (NASDAQ:ENVB) stock in terms of its daily trading volume indicates that the 3-month average is 3.14 million.
Current records show that the company has 21.33M in outstanding shares. The insiders’ percentage holdings are 25.53% of outstanding shares while the percentage share held by institutions stands at 6.00%. But the -33.80% downside, the stock’s price has registered year-to-date as of today’s value, will likely reignite investor interest given the prospect of it rallying even higher.